TFR Capital, LLC.: NEE position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of TFR Capital, LLC. on NEE, newest first. How the timeline and the estimate are built.
TFR Capital, LLC. held 23,948 NEE shares at 2026-06-30 per its 13F-HR filed 2026-08-06.
the latest 13F is the newest step
- period ended2026-06-3013F 23,948 sharesChange vs previous 13F +17,832 shares
0.59% of the 13F portfolio, value $2,101,916.
13F-HR 0001765380-26-000301 filed by TFR Capital, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 6,116 sharesChange vs previous 13F +1,863 shares
0.17% of the 13F portfolio, value $568,054.
13F-HR 0001765380-26-000141 filed by TFR Capital, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 4,253 sharesChange vs previous 13F -727 shares
0.11% of the 13F portfolio, value $341,431.
13F-HR 0001765380-26-000035 filed by TFR Capital, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 4,980 sharesChange vs previous 13F -56 shares
0.13% of the 13F portfolio, value $375,940.
13F-HR 0001765380-25-000435 filed by TFR Capital, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F/A 5,036 sharesChange vs previous 13F +364 shares
0.13% of the 13F portfolio, value $349,599.
13F-HR/A 0001765380-25-000262 filed by TFR Capital, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 4,672 sharesChange vs previous 13F not available
0.14% of the 13F portfolio, value $331,198.
13F-HR 0001765380-25-000159 filed by TFR Capital, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).